| Entry |
|
|---|
| Name |
Collagenase clostridium histolyticum (USAN);
Collagenase (Clostridium histolyticum) (JAN);
Collagenase santyl (TN);
Xiaflex (TN)
|
|---|
| Product |
|
|---|
| Source |
Hathewaya histolytica (Clostridium histolyticum) [TAX: 1498]
|
|---|
| Remark |
| Therapeutic category: | 2900 |
|
|---|
| Efficacy |
Collagen hydrolysis, Debriding ointment |
|---|
| Comment |
Collagenase clostridium histolyticum [EC: 3.4.24.3] is bacterial enzymes produced the Clostridium histolyticum.
Treatment of Dupuytren's disease
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09AB Enzymes
M09AB02 Collagenase clostridium histolyticum
D09596 Collagenase clostridium histolyticum (USAN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Collagenase
D09596 Collagenase clostridium histolyticum (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
29 Other agents affecting individual organs
290 Other agents affecting individual organs
2900 Other agents affecting individual organs
D09596 Collagenase clostridium histolyticum (USAN); Collagenase (Clostridium histolyticum) (JAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09596
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09596
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09596
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09596
 |
|---|
| Other DBs |
| CAS: | 955089-04-0 955089-06-2 |
|
|---|
| LinkDB |
 |
|---|
